Troy  Wichterman net worth and biography

Troy Wichterman Biography and Net Worth

Troy Wichterman has been Chief Financial Officer since November 2021. Before his appointment as
Chief Financial Officer, Mr. Wichterman served as Vice President, Finance since November 2019. In that
role, Mr. Wichterman oversaw the finance and accounting organization in the areas of integrating
acquired businesses, acquisition due diligence and deal structure, SEC reporting, financial planning and
analysis, operational finance, and audit compliance. Mr. Wichterman also served as Director of Financial
Planning and Analysis from June 2016 to November 2019 and Financial Analyst from February 2015 to
June 2016. Prior to joining the company, he was most recently a Senior Financial Analyst, Acquisitions at
Ventas, a public healthcare REIT, from January 2013 to September 2014. Prior to Ventas, he was most
recently a Senior Portfolio Analyst at Heitman, a private equity REIT, from June 2009 – January 2013 and
began his career as an Auditing Associate at PwC in Chicago from 2008 to 2009. Mr. Wichterman is a
CPA (inactive) and holds a Bachelor of Business Administration degree and a Master of Accountancy
degree from the University of Wisconsin – Madison.

What is Troy Wichterman's net worth?

The estimated net worth of Troy Wichterman is at least $3.24 million as of February 12th, 2025. Mr. Wichterman owns 121,620 shares of BioLife Solutions stock worth more than $3,243,605 as of February 22nd. This net worth estimate does not reflect any other investments that Mr. Wichterman may own. Additionally, Mr. Wichterman receives an annual salary of $485,200.00 as CFO at BioLife Solutions. Learn More about Troy Wichterman's net worth.

How old is Troy Wichterman?

Mr. Wichterman is currently 39 years old. There are 6 older executives and no younger executives at BioLife Solutions. The oldest executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who is 64 years old. Learn More on Troy Wichterman's age.

What is Troy Wichterman's salary?

As the CFO of BioLife Solutions, Inc., Mr. Wichterman earns $485,200.00 per year. The highest earning executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who commands a salary of $1,630,000.00 per year. Learn More on Troy Wichterman's salary.

How do I contact Troy Wichterman?

The corporate mailing address for Mr. Wichterman and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at rdegreef@biolifesolutions.com. Learn More on Troy Wichterman's contact information.

Has Troy Wichterman been buying or selling shares of BioLife Solutions?

Over the course of the past ninety days, Troy Wichterman has sold $30,888.60 of BioLife Solutions stock. Most recently, Troy Wichterman sold 159 shares of the business's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $26.54, for a transaction totalling $4,219.86. Following the completion of the sale, the chief financial officer now directly owns 121,620 shares of the company's stock, valued at $3,227,794.80. Learn More on Troy Wichterman's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 68 times. They sold a total of 179,217 shares worth more than $3,860,661.93. The most recent insider tranaction occured on February, 12th when EVP Aby J Mathew sold 92 shares worth more than $2,441.68. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 2/12/2025.

Troy Wichterman Insider Trading History at BioLife Solutions

Troy Wichterman Buying and Selling Activity at BioLife Solutions

This chart shows Troy Wichterman's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$31ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $26.67
Low: $26.42
High: $27.90

50 Day Range

MA: $26.93
Low: $24.98
High: $28.49

2 Week Range

Now: $26.67
Low: $14.50
High: $29.55

Volume

259,865 shs

Average Volume

238,085 shs

Market Capitalization

$1.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91